U.S. advisers reject higher dose of Novartis lung drug
Novartis AG failed to win support from a U.S. advisory panel for the highest proposed dose of a new lung drug, a setback that could delay development of a potential blockbuster medicine.
Join the discussion below, or Read more at WOZZ-FM Appleton.
#1 Mar 9, 2011
COPD is something you never recover from.
All you can do is delay its progress. It's 3rd or 4th killer in the US. There should be some common sense used and anything that may help should be seriously considered. What works for one person may not help another, so there has to be some leway in type of drug/s tried and used.
#2 Mar 25, 2011
Add your comments below
|Analyst: A Complete List of All Major Biosimila... (Apr '15)||Apr '15||DawnMEcker||1|
|Teva gets Fda Ok for generic of herpes drug Famvir (Oct '07)||Jun '14||Liza_R||5|
|Women With Breast Cancer No Longer Have to Sett... (Aug '06)||Nov '13||kit||64|
|New warnings on ADHD drugs (Aug '06)||Sep '13||Joey||6|
|For GSK, other drug giants, pipelines rebound -... (Feb '13)||Feb '13||GSK Maims Kills||2|
|Mylan Inc. Tries to Get Its Hands on Ranbaxy La... (Dec '12)||Dec '12||Jrseyan||1|
|FDA Is Rejecting More New Drugs - (Aug '07)||Dec '11||Pamela McCreary||3|
Find what you want!
Search Novartis Forum Now
Copyright © 2016 Topix LLC